Medivation Inc (MDVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MDVN | BGNE | SRPT | ||
| Company | Medivation Inc | Beigene Ltd ADR | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 81.48 | 152.11 | 127.53 | ||
| High | 81.48 | 154.47 | 131.46 | ||
| Low | 81.48 | 150.73 | 125.62 | ||
| Last | 81.48 | 153.58 | 128.77 | ||
| Change | +0.04 | +5.02 | +1.38 | ||
| % Change | +0.05% | +3.38% | +1.08% | ||
| Volume | 8,577 | 208,400 | 1,236,000 | ||
| 20-Day Average Volume | 4,748,854 | 183,420 | 747,475 | ||
| Previous Close | 81.44 | 148.56 | 127.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 81.02 | 144.35 | 123.07 | ||
| 20-Day Raw Stochastic | 100.00% | 82.21% | 84.26% | ||
| 20-Day Relative Strength | 84.34% | 52.77% | 58.26% | ||
| Weighted Alpha | +108.00 | -36.97 | +21.17 | ||
| Today's Opinion | N/A | 88% Sell | 88% Buy | ||
| Previous Opinion | N/A | 88% Sell | 80% Buy | ||
| Last Month's Opinion | N/A | 80% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.56% since 09/21/16 | +18.58% since 04/19/24 | +11.37% since 04/19/24 | ||
| Low | 80.94 on 09/22/16 | 129.96 on 04/22/24 | 114.48 on 04/22/24 | ||
| High | 81.48 on 09/28/16 | 154.47 on 04/26/24 | 131.46 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | +1.41% since 08/26/16 | -0.15% since 03/26/24 | +0.41% since 03/26/24 | ||
| Low | 80.25 on 08/30/16 | 126.97 on 04/19/24 | 114.37 on 04/19/24 | ||
| High | 81.48 on 09/28/16 | 159.34 on 04/01/24 | 131.46 on 04/26/24 | ||
| 3-Month | |||||
| %Chg | +40.99% since 06/28/16 | -5.14% since 01/26/24 | +8.46% since 01/26/24 | ||
| Low | 58.80 on 07/05/16 | 126.97 on 04/19/24 | 114.37 on 04/19/24 | ||
| High | 81.48 on 09/28/16 | 184.80 on 03/13/24 | 143.00 on 02/16/24 | ||
| 6-Month | |||||
| %Chg | +97.53% since 03/28/16 | -7.40% since 10/26/23 | +15.39% since 10/26/23 | ||
| Low | 35.55 on 03/29/16 | 126.97 on 04/19/24 | 55.25 on 10/31/23 | ||
| High | 81.48 on 09/28/16 | 205.40 on 11/14/23 | 143.00 on 02/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,514,170 | 14,688,390 | 12,169,536 | ||
| Shares Outstanding, K | 165,010 | 95,640 | 94,506 | ||
| Annual Sales | 943,260,000 | 2,458,780,000 | 1,243,340,000 | ||
| Annual Net Income | 244,730,000 | -881,710,000 | -535,980,000 | ||
| Last Quarter Sales | 206,170,000 | 634,410,000 | 396,780,000 | ||
| Last Quarter Net Income | -403,920,000 | -367,550,000 | 45,650,000 | ||
| 60-Month Beta | 0.60 | 0.61 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 08/09/16 | -3.53 on 02/26/24 | 0.47 on 02/28/24 | ||
| Latest Earnings Date | 11/03/16 | 05/02/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 105.74 | 0.00 | 0.00 | ||